Leong Rachel, Dave Nisha J, Griffith Daniel P, Guo Anna, Easley Kirk A, Galloway John R, Ziegler Thomas R, Zhao Vivian M
Nutrition and Metabolic Support Service, Emory University Hospital, Atlanta, Georgia, USA.
Department of Pharmaceutical Services, Emory University Hospital, Atlanta, Georgia, USA.
JPEN J Parenter Enteral Nutr. 2025 Aug;49(6):783-790. doi: 10.1002/jpen.2788. Epub 2025 Jun 22.
We determined the incidence of catheter-related bloodstream infections in adult patients requiring home parenteral nutrition (HPN) while receiving sodium citrate locks.
We conducted a single-center descriptive cohort study involving 38 adults who required HPN from January 1, 2020, to August 31, 2022. The exact method, assuming a Poisson distribution, was used to estimate the incidence rate of catheter-related bloodstream infections per 1000 catheter days among patients receiving sodium citrate locks. Univariate and multivariate analyses using Poisson regression and frailty models were employed to evaluate predictive factors.
Thirty-eight patients received sodium citrate locks, with 65.8% women (mean age, 50.2 ± 14.5 years). The average length of HPN was 3.6 years. Forty-six catheter-related bloodstream infections occurred during 20,085 catheter days, demonstrating an incidence rate of 2.3 (95% confidence interval, 1.7-3.1) per 1000 catheter days. Peripheral-inserted central catheters had a higher incidence rate (3.9 per 1000 catheter days) than Hickman catheters (2.2 per 1000 catheter days), with a hazard ratio of 1.27, indicating a 27% increased risk of catheter-related bloodstream infections. Univariate and multivariate Poisson regression analyses revealed that for every 1-h increase in HPN infusion duration (h/day), the incidence rate of catheter-related bloodstream infections is expected to increase by 10%.
Catheter-related bloodstream infections are common in adult patients requiring HPN. Sodium citrate locks may help prevent these infections. Recognizing predictive factors, such as the duration of parenteral infusion, can help healthcare providers develop more effective prevention strategies.
我们确定了接受枸橼酸钠封管的需要家庭肠外营养(HPN)的成年患者中导管相关血流感染的发生率。
我们进行了一项单中心描述性队列研究,纳入了2020年1月1日至2022年8月31日期间38例需要HPN的成年人。采用假设泊松分布的精确方法来估计接受枸橼酸钠封管的患者每1000导管日的导管相关血流感染发生率。使用泊松回归和脆弱模型进行单变量和多变量分析以评估预测因素。
38例患者接受了枸橼酸钠封管,其中65.8%为女性(平均年龄50.2±14.5岁)。HPN的平均时长为3.6年。在20085个导管日期间发生了46例导管相关血流感染,显示每1000导管日的发生率为2.3(95%置信区间,1.7 - 3.1)。外周静脉穿刺中心静脉导管的发生率(每1000导管日3.9例)高于希克曼导管(每1000导管日2.2例),风险比为1.27,表示导管相关血流感染风险增加27%。单变量和多变量泊松回归分析显示,HPN输注时长(小时/天)每增加1小时,导管相关血流感染的发生率预计增加10%。
导管相关血流感染在需要HPN的成年患者中很常见。枸橼酸钠封管可能有助于预防这些感染。识别诸如肠外输注时长等预测因素有助于医疗服务提供者制定更有效的预防策略。